ASMR: The Most Terrifying Diseases Ever

Scientific Concepts, Discoveries, and Nature/Biological Phenomena

Prion Diseases (Misfolded Proteins Causing Fatal Neurodegeneration)

Core concept: Prions are misfolded proteins that trigger other proteins to misfold, leading to progressive brain damage.

Key outcomes described:

• All are fatal and uncurable
• Fast-progressing with severe brain damage, described as a “sponge-like” brain due to brain atrophy
• Brain chain-reaction mechanism: the brain cannot remove misfolded proteins quickly enough, allowing them to spread

Disease examples:

Kuru

• Historical setting: Papua New Guinea, among the Fore people
• Associated practice: mortuary rituals / cannibalism (women and children reportedly had brain consumption; linked by the speaker to fat/nutrition)
• Incubation: decades-long (reported 30–50 years later)
• Symptoms:
  • Coordination/balance problems
  • Tremors and involuntary movements
  • Speech/swallowing difficulty
  • Progressive inability to walk, later inability to stand/eat
• “Laughing disease”: linked to misfolding in brain areas connected to emotion/tickling sensations (not universal)
• Epidemiology notes:
  • Peak mortality ~35 deaths per 1,000 per year (1940s–50s)
  • Cases declined after the practice ended
  • Last reported case: 2005

Creutzfeldt–Jakob Disease (CJD)

• Types:
  • Sporadic CJD: no clear external cause; described as spontaneous abnormal prion process
  • Variant CJD (vCJD): linked to exposure to BSE (“mad cow disease”) via beef consumption
• Symptoms described:
  • Rapid progression with dementia
  • Personality/behavior changes
  • Coordination problems
  • Visual abnormalities
  • Muscle jerks
  • Speech/walking difficulty
• Treatment described: no cure; only supportive symptom management (e.g., pain relief, antidepressants)
• Incidence figures cited (as quoted by speaker):
  • ~1–2 million per million per year (imprecise figure)
  • 500–600 cases annually in the US

Fatal Familial Insomnia (FFI)

• Genetics: autosomal dominant inheritance; mutation in PRNP (speaker mentions D178N and codon 129 methionine context)
• Neuropathology target: thalamus (sleep/consciousness and autonomic regulation)
• Symptom sequence:
  • Abnormal sleep → collapse of sleep architecture
  • Autonomic dysfunction (blood pressure, heartbeat, sweating, temperature regulation)
  • Weight loss, hallucinations
  • Balance/cognitive decline → dementia
• Treatment described: cannot cure; only symptomatic support
• Rarity: speaker states <1 per million, only hundreds of documented genetically confirmed cases
• Course described:
  • Average onset: 47.5 years
  • Duration: usually ~13 months (with range given)

---

Rabies (Lyssavirus Infection of the Central Nervous System)

Core concept: Lyssavirus infection reaches the central nervous system from peripheral nerves.

Transmission described:

• Via saliva through bites, scratches, or open wounds
• Dogs responsible for ~99% of cases (speaker claim)
• Bats also noted in the US

Pathogenesis described:

• Incubation can be months to up to a year
• Virus travels along peripheral nerves → encephalitis (brain inflammation)

Symptoms described:

• Fever, headache, weakness
• Burning/tingling/pain near bite
• Progression to “furious rabies” (agitation, hallucinations, confusion)
• Hydrophobia: throat spasms causing difficulty swallowing and breathing (not merely fear of water)
• Later: paralysis, coma, death

Prognosis/Treatment described:

• No cure after symptoms begin; survival is extremely rare
• Highly preventable with post-exposure vaccination
  • Vaccine uses a weakened virus to induce protection before symptoms start

Epidemiology cited:

• WHO: ~59,000 human deaths/year, mostly in Africa and Asia where vaccines are less accessible
• US: fewer than 10 cases annually (speaker claim)

---

Leprosy (Mycobacterium leprae; Chronic Infection With Nerve/Skin Damage)

Core concept: caused by Mycobacterium leprae, which grows extremely slowly.

Targets described:

• Peripheral nerves, skin, eyes, and nasal tissues

Course and signs described:

• Pale skin patches with reduced sensation (numbness)
• Gradual loss of sensation in hands/feet
• Injury/infection can damage fingers/toes; burns can occur due to lack of pain sensation
• Chronic nerve damage → tissue destruction and permanent disability

Contagion described:

• Speaker states it is not very contagious
• Requires prolonged close contact with an untreated infected person (possibly via respiratory droplets)
• Casual contact (e.g., handshakes) usually insufficient

Treatment described:

• Antibiotics: rifampicin, dapsone, clofazimine (multi-drug regimen) for 6–12 months
• Generally curable now, though severe nerve damage may remain irreversible

Historical note:

• Leprosaria (special hospitals) and stigma; speaker mentions Che Guevara’s historical involvement with leprosaria

---

Measles (Highly Contagious Viral Disease; Immune Suppression and Complications)

Core concept: measles virus spreads via airborne respiratory droplets/aerosols when an infected person coughs/sneezes/breathes.

Contagiousness described:

• Among the most contagious human infections
• Symptoms begin about 7–14 days after exposure

Symptoms described:

• Fever, cough, runny nose, red irritated eyes
• Koplik spots inside the mouth
• Widespread red rash

Complications described:

• Temporary immune system suppression
• Pneumonia and encephalitis
• Cited risks include:
  • 1 in 20 pneumonia
  • 1 in 1,000 encephalitis
  • US mortality figure cited: 1–3 deaths per 1,000 infected children

Epidemiology cited:

• WHO: ~11 million infections and ~95,000 deaths in 2024, mainly among under-vaccinated children

Prevention emphasized:

• Measles vaccination (speaker calls it an “oldest and popular vaccine”)

---

Plague (Yersinia pestis; Bubonic, Septicemic, Pneumonic Forms)

Core concept: caused by Yersinia pestis, historically responsible for the Black Death.

Transmission described:

• Bubonic plague: typically after a flea bite (historical rat/flea cycle)
• Pneumonic plague: can spread directly between humans via coughing/breathing

Forms and symptoms described:

Bubonic

• Fever, weakness, headache
• Extremely painful swollen lymph nodes

Septicemic

• Bacteria in bloodstream → severe sepsis, internal bleeding, shock, tissue death
• Speaker links tissue death to “black” appearance

Pneumonic

• Severe pneumonia
• Chest pain and difficulty breathing
• Bloody sputum

Severity/speed described:

• Untreated septicemic/pneumonic plague can have very high fatality rates
• Speaker claims pneumonic can become fatal in ~18–24 hours after severe symptoms begin

Epidemiology/Treatment described:

• US average: ~7 cases/year (speaker claim)
• Endemic regions mentioned: parts of Madagascar, DRC, and Peru
• Treatment: antibiotics; prompt treatment improves survival

---

Cholera (Vibrio cholerae Toxin Causing Massive Watery Diarrhea)

Core concept: caused by toxin-producing strains of Vibrio cholerae.

Transmission described:

• Contaminated water/food (including ponds/wells mentioned by speaker)

Mechanism described:

• Bacteria remain mainly in the intestines and release a toxin
• Toxin triggers intestinal cells to release huge amounts of water and electrolytes

Symptoms described:

• Massive watery diarrhea (“rice-water stool”)
• Rapid fluid loss → extreme thirst, muscle cramps, low blood pressure, rapid heartbeat, kidney failure, death

Key point emphasized:

• Death occurs largely due to dehydration, not direct tissue invasion

Treatment described:

• Prompt fluid and electrolyte replacement (IV mentioned)
• Mortality reduced to below 1%
• Without treatment: mortality ~50% (speaker claim)

Epidemiology cited:

• WHO: ~1.3–4 million infections and ~21,000–143,000 deaths/year

Prevention emphasized:

• Access to purified water

---

Fibrodysplasia Ossificans Progressiva (FOP; Genetic Disorder Causing Heterotopic Bone Formation)

Core concept: a genetic disorder where the body forms mature bone in places where bone should not exist.

Genetics described:

• Mutation in ACVR1 disrupting bone-formation signaling

Hallmark early sign:

• Abnormality of the big toes at birth (otherwise relatively healthy)

Disease progression described:

• Childhood flare-ups with painful swelling
• After flare-ups, muscles/tendons/ligaments can be replaced by mature bone
• Over years: bridges of extra bone form; joints become fixed
• Functional deterioration:
  • Reduced neck/arm movement
  • Hips/knees lock
  • Jaw can’t open
  • Wheelchair dependence

Risks described:

• Injury can worsen disease:
  • Falls, biopsies, operations, intramuscular injections can trigger new bone formation
  • Surgery to remove extra bone may cause more ossification

Epidemiology described:

• Prevalence estimates: about 0.6–1.36 per million
• Older estimate: ~1 per 2 million
• Not immediately fatal; median lifespan cited: ~56 years (historical study)
• Major cause of premature death:
  • Thoracic insufficiency syndrome from chest/spinal deformities restricting breathing → respiratory/cardiovascular failure

New discoveries/therapies mentioned:

• 2023 FDA approval: palovarotene (Sohonos) to reduce new bone formation in certain patients
• August 19, 2026 FDA approval: another medication for adults to reduce new ossification and flare-ups (speaker claim)

---

Researchers or Sources Featured (Explicitly Named)

• Dr. House (mentioned as inspiration/“another episode”; character/source)
• CDC (cited for CJD, rabies, and plague case figures; speaker quotes estimates)
• WHO (cited for rabies, measles, cholera, and plague figures)
• FDA (cited for FOP drug approvals)
• Che Guevara (mentioned historically as a medical student visiting leprosaria)
• Michael from The Office (mentioned as a cultural reference related to rabies fundraising; not a scientific source)